Literature DB >> 9402354

Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis.

F March1, X Garriga, P Rodríguez, C Moreno, M Garrigó, P Coll, G Prats.   

Abstract

We describe five compliant patients with human immunodeficiency virus (HIV)-associated tuberculosis (TB) that relapsed, with acquisition of resistance by the original Mycobacterium tuberculosis strains. Both the first and second isolates from each patient had the same IS (insertion sequence) 6110-based DNA fingerprint patterns. Three of the five patients developed TB that was resistant to rifampin alone; no mutation in the region of the rpoB gene was detected by a line probe assay in two of the isolates from these patients. We discuss several factors presumably associated with acquired drug resistance in HIV-infected patients, including exogenous reinfection, drug interactions, malabsorption of drugs, and the presence of a large organism burden.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402354     DOI: 10.1086/516065

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Recent Developments in Epidemiology, Treatment, and Diagnosis of Tuberculosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

2.  Drug-resistant tuberculosis: what are the treatment options?

Authors:  Amr S Albanna; Dick Menzies
Journal:  Drugs       Date:  2011-05-07       Impact factor: 9.546

3.  Rifampicin-monoresistant Mycobacterium tuberculosis disease among children in Cape Town, South Africa.

Authors:  A Dramowski; M M Morsheimer; A M Jordaan; T C Victor; P R Donald; H S Schaaf
Journal:  Int J Tuberc Lung Dis       Date:  2012-01       Impact factor: 2.373

4.  Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.

Authors:  Helen S Cox; Cheryl McDermid; Virginia Azevedo; Odelia Muller; David Coetzee; John Simpson; Marinus Barnard; Gerrit Coetzee; Gilles van Cutsem; Eric Goemaere
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

5.  Rifampin-resistant Tuberculosis in the United States, 1998-2014.

Authors:  Lisa Sharling; Suzanne M Marks; Michael Goodman; Terence Chorba; Sundari Mase
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

6.  Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India.

Authors:  Petros Isaakidis; Mrinalini Das; Ajay M V Kumar; Christopher Peskett; Minni Khetarpal; Arun Bamne; Balkrishna Adsul; Mamta Manglani; Kuldeep Singh Sachdeva; Malik Parmar; Avinash Kanchar; B B Rewari; Alaka Deshpande; Camilla Rodrigues; Anjali Shetty; Lorraine Rebello; Peter Saranchuk
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

Review 7.  Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment.

Authors:  Anastasia Koch; Helen Cox; Valerie Mizrahi
Journal:  Curr Opin Pharmacol       Date:  2018-06-06       Impact factor: 5.547

8.  Low Occurrence of Tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients from an Urban Setting, with a Long-Running DOTS Program in Zambia.

Authors:  Chanda Mulenga; Allan Chonde; Innocent C Bwalya; Nathan Kapata; Mathilda Kakungu-Simpungwe; Sven Docx; Krista Fissette; Isdore Chola Shamputa; Françoise Portaels; Leen Rigouts
Journal:  Tuberc Res Treat       Date:  2010-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.